Skip to content

The Effect of Intravenous Immunoglobulin on Jaundice

The Effect of Intravenous Immunoglobulin on Jaundice Induced by Neonatal Isoimmune Hemolytic Disease

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171218037936N3
Enrollment
76
Registered
2020-03-07
Start date
2019-03-22
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaundice of neonates. Neonatal jaundice due to other specified excessive hemolysis

Interventions

Intervention 1: Intervention group 1: The first group (prophylaxis group) included the neonates who received IVIG at dose of 0.5 g / kg within 4 hours. IVIG used in the study had the trade name of Int

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 30 Days

Inclusion criteria

Inclusion criteria: Neonates with Jaundice Informed consent of parents

Exclusion criteria

Exclusion criteria: Neonates weighing less than 2500 grams

Design outcomes

Primary

MeasureTime frame
Duration of hospitalization. Timepoint: Once on the time of discharge. Method of measurement: The length of time that the neonate is hospitalized.;Duration of phototherapy. Timepoint: Once on the time of discharge. Method of measurement: Using a phototherapy machine.;Plasmapheresis. Timepoint: Once on the time of discharge. Method of measurement: Based on file information.;Bilirubin. Timepoint: Measured 4 times every 12 hours. Method of measurement: Blood sampling.;Hemoglobin. Timepoint: Measured 4 times every 12 hours. Method of measurement: Blood sampling.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKamran Dehghan

Oroumia University of Medical Sciences

dehghan.k@umsu.ac.ir+98 44 3365 4154

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026